These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2934906)

  • 1. [General acetylating capacity of the body of patients with rosacea].
    Alekseev IuV; Gladkikh SP; Mashkilleĭson AL; Altynbaeva RD; Evstaf'eva OL
    Vestn Dermatol Venerol; 1985 Oct; (10):21-2. PubMed ID: 2934906
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acetylation phenotype in patients with cancer of the bladder. Preliminary report].
    Skretowicz J; Polakowski P; Jeromin L; Zasada M; Szymańska J; Krajewska B
    Med Pr; 1988; 39(4):241-5. PubMed ID: 3237058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No effect of zinc on acetylating capacity.
    Fjellner B; Beitner H; Seideman P
    N Engl J Med; 1981 Apr; 304(15):912. PubMed ID: 7207531
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acetylation phenotype in atopic diseases].
    Patkowski J; Małolepszy J; Milejski P; Orzechowska-Juzwenko K; Nittner-Marszalska M
    Pol Tyg Lek; 1987 Jul; 42(29):870-3. PubMed ID: 3684766
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acetylation phenotype in patients with systemic lupus erythematosus].
    Iakushkevich TN; Tareeva IE; Tuganbekova SK; Kovaleva VL; Evstaf'eva OL
    Ter Arkh; 1985; 57(8):82-4. PubMed ID: 3865448
    [No Abstract]   [Full Text] [Related]  

  • 6. Acetylator phenotype in rheumatoid arthritis.
    Ehrenfeld M; Zylber-Katz E; Levy M
    Isr J Med Sci; 1983 Apr; 19(4):368-70. PubMed ID: 6853137
    [No Abstract]   [Full Text] [Related]  

  • 7. Acetylator phenotype in Iraqi patients with discoid lupus erythematosus.
    Najim RA; Farid YY; Shihab SA
    Saudi Med J; 2004 Oct; 25(10):1530-2. PubMed ID: 15494852
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acetylation phenotype in varnishers].
    Jendryczko A; Kucharz E
    Pol Tyg Lek; 1984 Mar; 39(12):393-4. PubMed ID: 6473193
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acetylation phenotype and its significance in allergic diseases].
    Orzechowska-Juzwenko K; Milejski P; Patkowski J; Małolepszy J
    Pol Tyg Lek; 1986 Jan; 41(1):25-8. PubMed ID: 3703721
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acetylation phenotype in patients with periodic disease].
    Podymov VK; Vinogradova OM; Kovaleva VL; Kochubeĭ LN; Galstian SM
    Ter Arkh; 1988; 60(6):93-5. PubMed ID: 2974645
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acetylation phenotype in psoriasis].
    Olszewska Z; Orłowska-Westwood B; Orszulak D; Jabłkowska-Gajdzińska J; Skretkowicz J
    Przegl Dermatol; 1980; 67(1):19-22. PubMed ID: 7375649
    [No Abstract]   [Full Text] [Related]  

  • 12. [Distribution pattern of acetylator phenotypes: effect of age].
    Gachályi B; Vas A; Hajös P; Káldor A
    Orv Hetil; 1984 Jan; 125(2):75-7. PubMed ID: 6694835
    [No Abstract]   [Full Text] [Related]  

  • 13. Acetylator phenotyping in patients with malignant lymphomas, using caffeine as the metabolic probe.
    William BM; Abdel-tawab AM; Hassan EA; Mohamed OF
    Pol J Pharmacol; 2004; 56(4):445-9. PubMed ID: 15520499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acetylation in disseminated sclerosis and amyotrophic lateral sclerosis].
    Zavalishin IA; Kovaleva VL; Larskiĭ EG; Mzhel'skaia TI; Niiazbekova AS
    Sov Med; 1986; (9):31-4. PubMed ID: 3798218
    [No Abstract]   [Full Text] [Related]  

  • 15. [Polymorphic acetylation in women with genital neoplasms].
    Tomaszkiewicz T; Markowska J; Simm S; Herwichowska K
    Pol Tyg Lek; 1979 Sep; 34(39):1521-3. PubMed ID: 503961
    [No Abstract]   [Full Text] [Related]  

  • 16. Oxidative stress and ferritin expression in the skin of patients with rosacea.
    Tisma VS; Basta-Juzbasic A; Jaganjac M; Brcic L; Dobric I; Lipozencic J; Tatzber F; Zarkovic N; Poljak-Blazi M
    J Am Acad Dermatol; 2009 Feb; 60(2):270-6. PubMed ID: 19028405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylator phenotype in patients with breast cancer.
    Bulovskaya LN; Krupkin RG; Bochina TA; Shipkova AA; Pavlova MV
    Oncology; 1978; 35(4):185-8. PubMed ID: 704038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of acetylator phenotype and renal function on the antihypertensive effect of hydralazine.
    Koopmans PP; Hoefnagels WH; Huysmans FT; Thien T
    Neth J Med; 1984; 27(3):69-73. PubMed ID: 6709112
    [No Abstract]   [Full Text] [Related]  

  • 19. Acetylator phenotype in patients with lung carcinoma--a negative report.
    Burgess EJ; Trafford JA
    Eur J Respir Dis; 1985 Jul; 67(1):17-9. PubMed ID: 4054252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatic acetylator phenotype in diabetic polyneuropathy].
    Ladero Quesada JM; Arrojo Romero A; Cocero Oviedo E; Gómez Pérez M; Cano Iglesias F; Franco Carcedo C; Camarero González E; Sánchez Creus P
    Rev Clin Esp; 1983 Mar; 168(6):399-402. PubMed ID: 6878767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.